154: Beneficial Effect of Omega-3 Fatty Acids on in Sirolimus/Everolimus-Induced Hypertriglyceridemia in Heart Transplant Recipients
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The few studies of omega-3 fatty acid supplementation in children and adolescents with hypertriglyceridemia have not shown a significant triglyceride-lowering effect.
“the few studies of n-3 FA supplementation in children/ adolescents with HTG have not shown a significant triglyceride-lowering effect.78,79,81”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [78]
Prescription doses of omega-3 fatty acids appear as safe for managing elevated triglycerides in adolescents and children as young as 10 years as for adults.
“Prescription doses of n-3 FA appear to be as safe for the management of elevated triglycerides in adolescents and children as young as 10 years of age as they are for adults.78,79”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [78]
- Authors
- Celik, S., Doesch, A. O., Erbel, C., Koch, A., & Dengler, T. J.
- Affiliations
- University Hospital Heidelberg (DE)
- Venue
- The Journal of Heart and Lung Transplantation
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 27
- Issue
- 2
- Pages
- S115
- ISSN
- 1053-2498 (ISSN-L)
- OpenAlex
- W2115093088
- Cited by
- 0
- References
- 0
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Heart and Lung Transplantation (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- omega-3 fatty acids, hypertriglyceridemia, rapamycin, everolimus, mTOR inhibitors, heart transplantation, hyperlipidemia, immunosuppression, LDL cholesterol, triglycerides, cardioprotection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
